US2004019929A1PendingUtilityA1
Aromatic amino acid biosynthetic enzymes
Priority: Dec 4, 1998Filed: Jul 21, 2003Published: Jan 29, 2004
Est. expiryDec 4, 2018(expired)· nominal 20-yr term from priority
C12Y 504/99005C12Y 103/01012A61K 38/00C12N 9/90C12N 15/8243C07K 2319/00C12N 9/001C12N 15/8251
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to an isolated nucleic acid fragment encoding a tyrosine biosynthetic enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the tyrosine biosynthetic enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the tyrosine biosynthetic enzyme in a transformed host cell.
Claims
exact text as granted — not AI-modified1 . An isolated polynucleotide comprising:
(a) a nucleotide sequence encoding a polypeptide having chorismate mutase activity, wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 80% sequence identity based on the Clustal pairwise alignment method with default parameters of KTUPLE=1 GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5, or (b) the complement of the nucleotide sequence, wherein the complement and the nucleotide sequence contain the same number of nucleotides and are 100% complementary.
2 . The polynucleotide of claim 1 , wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 90% sequence identity based on the Clustal alignment method.
3 . The polynucleotide of claim 1 , wherein the amino acid sequence of the polypeptide and the amino acid sequence of SEQ ID NO:16 have at least 95% sequence identity based on the Clustal alignment method.
4 . The polynucleotide of claim 1 wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:16.
5 . The polynucleotide of claim 1 , wherein the nucleotide sequence comprises the nucleotide sequence of SEQ ID NO:15.
6 . A recombinant DNA construct comprising the polynucleotide of claim 1 operably linked to at least one regulatory sequence.
7 . A cell comprising the polynucleotide of claim 1 .
8 . The cell of claim 7 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell and a plant cell.
9 . A transgenic plant comprising the polynucleotide of claim 1 .
10 . A virus comprising the polynucleotide of claim 1 .
11 . A method for transforming a cell comprising introducing into a cell the polynucleotide of claim 1 .
12 . A method for producing a transgenic plant comprising (a) transforming a plant cell with the polynucleotide of claim 1 and (b) regenerating a plant from the transformed plant cell.
13 . A vector comprising the polynucleotide of claim 1 .
14 . A seed comprising the recombinant DNA construct of claim 6.Join the waitlist — get patent alerts
Track US2004019929A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.